SCHEMBL7119934

SCHEMBL7119934

CC(=O)c1cccc(NC(=O)c2cc([N+](=O)[O-])ccc2Cl)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 10/20 0.73
SMN1; SMN2 Q16637 5/20 0.73
KMT2A Q03164 4/20 0.73
MAPT P10636 4/20 0.73
MEN1 O00255 3/20 0.73
MAPK1 P28482 3/20 0.73
CYP3A4 P08684 2/20 0.73
PPARG P37231 2/20 0.73
LMNA P02545 1/20 0.73
TP53 P04637 1/20 0.73
CYP1A2 P05177 1/20 0.73
CYP2D6 P10635 1/20 0.73
CYP2C9 P11712 1/20 0.73
PKM P14618 1/20 0.73
TSHR P16473 1/20 0.73
NFKB1 P19838 1/20 0.73
CYP2C19 P33261 1/20 0.73
THPO P40225 1/20 0.73
MTOR P42345 1/20 0.73
PMP22 Q01453 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7122886 0.90 RORC (0.77) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL7130573 0.90 MEN1 (0.71) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL7130551 0.89 RORC (0.82) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL7119937 0.88 KMT2A (0.72) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL7127748 0.86 SMN1; SMN2 (0.74) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL18147368 0.86 RORC (0.78) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL7120440 0.85 SMN1; SMN2 (0.81) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL29369092 0.84 RORC (1.00) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL420231 0.84 RORC (1.00) RORCSMN1; SMN2KMT2AMAPTMEN1
SCHEMBL18146270 0.84 RORC (0.74) RORCSMN1; SMN2KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RORC 67/4885SMN1; SMN2 3743/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.